{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:40:30Z","timestamp":1792572030156,"version":"4.5.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230786-4\"><jats:title>Importance<\/jats:title><jats:p>A body of pathological and clinical evidence supports the position that the fallopian tube is the site of origin for a large proportion of high-grade serous ovarian cancers. Consequently, salpingectomy is now considered for permanent contraception (in lieu of tubal ligation) or ovarian cancer prevention (performed opportunistically at the time of surgical procedures for benign gynecologic conditions).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230786-5\"><jats:title>Objective<\/jats:title><jats:p>To evaluate the association between salpingectomy and the risk of invasive epithelial ovarian, fallopian tube, and peritoneal cancer.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230786-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This population-based retrospective cohort study included all women aged 18 to 80 years who were eligible for health care services in Ontario, Canada. Participants were identified using administrative health databases from Ontario between January 1, 1992, and December 31, 2019. A total of 131 516 women were included in the primary (matched) analysis. Women were followed up until December 31, 2021.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230786-7\"><jats:title>Exposures<\/jats:title><jats:p>Salpingectomy (with and without hysterectomy) vs no pelvic procedure (control condition) among women in the general population.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230786-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Women with a unilateral or bilateral salpingectomy in Ontario between April 1, 1992, and December 31, 2019, were matched 1:3 to women with no pelvic procedure from the general population. Cox proportional hazards regression models were used to estimate the hazard ratios (HRs) and 95% CIs for ovarian, fallopian tube, and peritoneal cancer combined.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230786-9\"><jats:title>Results<\/jats:title><jats:p>Among 131 516 women (mean [SD] age, 42.2 [7.6] years), 32\u202f879 underwent a unilateral or bilateral salpingectomy, and 98\u202f637 did not undergo a pelvic procedure. After a mean (range) follow-up of 7.4 (0-29.2) years in the salpingectomy group and 7.5 (0-29.2) years in the nonsurgical control group, there were 31 incident cancers (0.09%) and 117 incident cancers (0.12%), respectively (HR,\u20090.82; 95% CI, 0.55-1.21). The HR for cancer incidence was 0.87 (95% CI, 0.53-1.44) when comparing those with salpingectomy vs those with hysterectomy alone.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230786-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cohort study, no association was found between salpingectomy and the risk of ovarian cancer; however, this observation was based on few incident cases and a relatively short follow-up time. Studies with additional years of follow-up are necessary to define the true level of potential risk reduction with salpingectomy, although longer follow-up will also be a challenge unless collaborative efforts that pool data are undertaken.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.27198","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T15:31:08Z","timestamp":1691767868000},"page":"e2327198","source":"Crossref","is-referenced-by-count":12,"title":["Salpingectomy and the Risk of Ovarian Cancer in Ontario"],"prefix":"10.1001","volume":"6","author":[{"given":"Vasily","family":"Giannakeas","sequence":"first","affiliation":[{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, Ontario, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"ICES, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ally","family":"Murji","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, Ontario, Canada"},{"name":"Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine L.","family":"Lipscombe","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, Ontario, Canada"},{"name":"ICES, Toronto, Ontario, Canada"},{"name":"Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Narod","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, Ontario, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kotsopoulos","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, Ontario, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"3","key":"zoi230786r2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.ygyno.2015.06.016","article-title":"Why have ovarian cancer mortality rates declined? part II. case-fatality.","volume":"138","author":"Sopik","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"9609","key":"zoi230786r3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"zoi230786r4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology.","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"zoi230786r5","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1097\/AOG.0000000000003164","article-title":"ACOG Committee opinion No. 774: opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention.","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"4","key":"zoi230786r6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/AOG.0000000000003165","article-title":"ACOG Committee opinion No. 774 summary: opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention.","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"49","key":"zoi230786r7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3238\/arztebl.m2022.0232","article-title":"Opportunistic salpingectomy for the primary prevention of ovarian cancer.","volume":"119","author":"Runnebaum","year":"2022","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"zoi230786r8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jogc.2016.12.005","article-title":"No. 344\u2014opportunistic salpingectomy and other methods of risk reduction for ovarian\/fallopian tube\/peritoneal cancer in the general population.","volume":"39","author":"Salvador","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"zoi230786r9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2018.11.009","article-title":"The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.","volume":"152","author":"Subramaniam","year":"2019","journal-title":"Gynecol Oncol"},{"key":"zoi230786r10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","article-title":"Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis.","volume":"55","author":"Yoon","year":"2016","journal-title":"Eur J Cancer"},{"key":"zoi230786r11","doi-asserted-by":"publisher","author":"Hanley","year":"2020","DOI":"10.1016\/j.ajog.2020.02.005"},{"issue":"7","key":"zoi230786r12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jmig.2019.02.003","article-title":"The trend, feasibility, and safety of salpingectomy as a form of permanent sterilization.","volume":"26","author":"Kim","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"zoi230786r14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"issue":"8","key":"zoi230786r15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"10","key":"zoi230786r16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","article-title":"The Reporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) statement.","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"4","key":"zoi230786r17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/(ISSN)1097-0258","article-title":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.","volume":"26","author":"Austin","year":"2007","journal-title":"Stat Med"},{"key":"zoi230786r18","doi-asserted-by":"publisher","author":"Hanley","year":"2018","DOI":"10.1016\/j.ajog.2018.05.019"},{"issue":"4","key":"zoi230786r19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/GRF.0000000000000315","article-title":"Risk-reducing surgery in women at low lifetime risk of developing ovarian carcinoma: opportunistic salpingectomy.","volume":"60","author":"Hanley","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"zoi230786r20","doi-asserted-by":"publisher","author":"Hanley","year":"2017","DOI":"10.1016\/j.ajog.2016.10.035"},{"issue":"2","key":"zoi230786r21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ygyno.2017.05.034","article-title":"Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.","volume":"146","author":"Dilley","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"1","key":"zoi230786r22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/humrep\/15.1.142","article-title":"Ovarian function before and after salpingectomy in artificial reproductive technology patients.","volume":"15","author":"Dar","year":"2000","journal-title":"Hum Reprod"},{"issue":"6","key":"zoi230786r23","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.fertnstert.2013.07.1997","article-title":"Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial.","volume":"100","author":"Findley","year":"2013","journal-title":"Fertil Steril"},{"key":"zoi230786r24","doi-asserted-by":"publisher","author":"Naumann","year":"2021","DOI":"10.1016\/j.ajog.2021.03.032"},{"issue":"2","key":"zoi230786r25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1701-2163(15)30659-9","article-title":"The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.","volume":"36","author":"Reade","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"zoi230786r26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fonc.2014.00021","article-title":"Prophylactic bilateral salpingectomy as a prevention strategy in women at high-risk of ovarian cancer: a mini-review.","volume":"4","author":"Schenberg","year":"2014","journal-title":"Front Oncol"},{"issue":"3","key":"zoi230786r27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","article-title":"Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.","volume":"135","author":"Lessard-Anderson","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"zoi230786r28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/aogs.2014.94.issue-1","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"zoi230786r29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study.","volume":"107","author":"Falconer","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"zoi230786r30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian cancer prevention.","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw Open"},{"key":"zoi230786r1","unstructured":"Canadian Cancer Society; Canadian cancer statistics 2022. November 2022. Accessed March 2023. https:\/\/cancer.ca\/en\/research\/cancer-statistics\/canadian-cancer-statistics."},{"key":"zoi230786r13","unstructured":"Society of Gynecologic Oncology. SGO clinical practice statement: salpingectomy for ovarian cancer prevention. November 1, 2013. Accessed July 20, 2023. https:\/\/www.sgo.org\/clinical-practice\/guidelines\/sgo-clinical-practice-statement-salpingectomy-for-ovarian-cancer-prevention\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2808216\/giannakeas_2023_oi_230786_1691002589.56902.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T15:31:12Z","timestamp":1691767872000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2808216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.27198","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]}}}